Reports
Reports
Sale
Pfizer Ltd.- Pfizer Inc. is a multinational pharmaceutical and biotechnology company with its main office in Manhattan, New York City, on 42nd Street. The firm develops, produces, and sells Biopharmaceuticals. The company sells drugs to treat a range of illnesses, including cancer, inflammation, immunological disorders, rare diseases, and ailments related to the heart, metabolism, and pain.
Daewon Pharmaceutical Co., Ltd.- Daewon Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical and medical products. The business offers anti-inflammatory analgesics, vitamins, and medications for chemotherapy, hyperlipidemia, respiratory, circulatory, antibiotic, and psychoneurosis purposes, as well as anaesthetic drugs. Aquafol Inj. and Pelubi Tab are brand names used by Daewon Pharmaceutical Co., Ltd. to market its goods. The business exports its goods to Asia, the Middle East, Latin America, and Africa. South Korea's capital city of Seoul is home to Daewon Pharmaceutical Co., Ltd. The corporation was established in 1961.
South Korea General Anesthesia Market Size
South Korea General Anesthesia Market Analysis
South Korea General Anesthesia Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Opportunities and Challenges in the Market
8 South Korea General Anesthesia Market Overview
8.1 Key Industry Highlights
8.2 South Korea General Anesthesia Historical Market (2018-2023)
8.3 South Korea General Anesthesia Market Forecast (2024-2032)
9 South Korea General Anesthesia Market by Drug Type
9.1 Propofol
9.1.1 Market Share
9.1.2 Historical Trend (2018-2023)
9.1.3 Forecast Trend (2024-2032)
9.2 Sevoflurane
9.2.1 Market Share
9.2.2 Historical Trend (2018-2023)
9.2.3 Forecast Trend (2024-2032)
9.3 Desflurane
9.3.1 Market Share
9.3.2 Historical Trend (2018-2023)
9.3.3 Forecast Trend (2024-2032)
9.4 Dexmedetomidine
9.4.1 Market Share
9.4.2 Historical Trend (2018-2023)
9.4.3 Forecast Trend (2024-2032)
9.5 Others
10 South Korea General Anesthesia Market by Route of Administration
10.1 Intravenous
10.1.1 Market Share
10.1.2 Historical Trend (2018-2023)
10.1.3 Forecast Trend (2024-2032)
10.2 Inhalation
10.2.1 Market Share
10.2.2 Historical Trend (2018-2023)
10.2.3 Forecast Trend (2024-2032)
11 South Korea General Anesthesia Market by Surgery Type
11.1 Heart Surgery
11.1.1 Market Share
11.1.2 Historical Trend (2018-2023)
11.1.3 Forecast Trend (2024-2032)
11.2 Cancer Surgery
11.2.1 Market Share
11.2.2 Historical Trend (2018-2023)
11.2.3 Forecast Trend (2024-2032)
11.3 Knee and Hip Replacements
11.3.1 Market Share
11.3.2 Historical Trend (2018-2023)
11.3.3 Forecast Trend (2024-2032)
11.4 General Surgery
11.4.1 Market Share
11.4.2 Historical Trend (2018-2023)
11.4.3 Forecast Trend (2024-2032)
11.5 Others
12 South Korea General Anesthesia Market by End-use
12.1 Hospitals
12.1.1 Market Share
12.1.2 Historical Trend (2018-2023)
12.1.3 Forecast Trend (2024-2032)
12.2 Ambulatory Surgical Centres
12.2.1 Market Share
12.2.2 Historical Trend (2018-2023)
12.2.3 Forecast Trend (2024-2032)
13 Market Dynamics
13.1 SWOT Analysis
13.1.1 Strengths
13.1.2 Weaknesses
13.1.3 Opportunities
13.1.4 Threats
13.2 Porter’s Five Forces Analysis
13.2.1 Supplier’s Power
13.2.2 Buyer’s Power
13.2.3 Threat of New Entrants
13.2.4 Degree of Rivalry
13.2.5 Threat of Substitutes
13.3 Key Indicators for Demand
13.4 Key Indicators for Price
14 Competitive Landscape
14.1 Market Structure
14.2 Company Profiles
14.2.1 Fresenius Kabi Korea Ltd
14.2.1.1 Company Overview
14.2.1.2 Product Portfolio
14.2.1.3 Demographic Reach and Achievements
14.2.1.4 Certifications
14.2.2 Hana Pharm Co., Ltd.
14.2.2.1 Company Overview
14.2.2.2 Product Portfolio
14.2.2.3 Demographic Reach and Achievements
14.2.2.4 Certifications
14.2.3 Daewon Pharmaceutical Co., Ltd
14.2.3.1 Company Overview
14.2.3.2 Product Portfolio
14.2.3.3 Demographic Reach and Achievements
14.2.3.4 Certifications
14.2.4 Pfizer Ltd.
14.2.4.1 Company Overview
14.2.4.2 Product Portfolio
14.2.4.3 Demographic Reach and Achievements
14.2.4.4 Certifications
14.2.5 Baxter International Inc.
14.2.5.1 Company Overview
14.2.5.2 Product Portfolio
14.2.5.3 Demographic Reach and Achievements
14.2.5.4 Certifications
14.2.6 AbbVie Inc.
14.2.6.1 Company Overview
14.2.6.2 Product Portfolio
14.2.6.3 Demographic Reach and Achievements
14.2.6.4 Certifications
14.2.7 Others
15 Key Trends and Developments in the Market
List of Key Figures and Tables
1. South Korea General Anesthesia Market: Key Industry Highlights, 2018 and 2032
2. South Korea General Anesthesia Historical Market: Breakup by Drug Type, 2018-2023
3. South Korea General Anesthesia Market Forecast: Breakup by Drug Type, 2024-2032
4. South Korea General Anesthesia Historical Market: Breakup by Route of Administration, 2018-2023
5. South Korea General Anesthesia Market Forecast: Breakup by Route of Administration, 2024-2032
6. South Korea General Anesthesia Historical Market: Breakup by Surgery Type, 2018-2023
7. South Korea General Anesthesia Market Forecast: Breakup by Surgery Type, 2024-2032
8. South Korea General Anesthesia Historical Market: Breakup by End-use, 2018-2023
9. South Korea General Anesthesia Market Forecast: Breakup by End-use, 2024-2032
10. South Korea General Anesthesia Market Structure
The South Korea general anesthesia market is projected to grow at a CAGR of 4.5% between 2024 and 2032.
Continuous research and development, an increased geriatric population, the development of the pharmaceutical sector, and growth opportunities for biostartups are the major drivers of the South Korea general anesthesia industry.
Research and development activities in the pharmaceutical sector and technological advances in the medical field are the key trends of the market.
The dominant type of general anesthesia in the South Korea general anesthesia industry are propofol, sevoflurane, desflurane, and dexmedetomidine, among others.
The major players in the industry are Fresenius Kabi Korea Ltd., Hana Pharm Co., Ltd., Daewon Pharmaceutical Co., Ltd., Pfizer Ltd., Baxter International Inc., and AbbVie Inc., among others.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.